CT-868
A Study to Assess CT-868 and the Relationship Between Insulin Secretory Response and Ambient Blood Glucose
Carmot Therapeutics, Inc · Phase 1 · Completed · Enrollment 32
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| CT-868 | n/r | n/r | n/r | n/r | n/r |
| Placebo | n/r | n/r | n/r | n/r | n/r |
| Active Comparator | n/r | n/r | n/r | n/r | n/r |
A count stays a count. This page does not turn a count into a percent.